Related Experiment Video
Updated: May 23, 2026
09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis B virus infection in children
Claudia Della Corte1, Donatella Comparcola, Valerio Nobili
1Hepato-Metabolic Department, Bambino Gesù Children Hospital, Rome, Italy.
Clinics and Research in Hepatology and Gastroenterology
|April 24, 2012
Summary
Neonatal Hepatitis B infection can occur in under 5% of infants born to infected mothers, even with vaccination. Most infants develop chronic hepatitis, often in immune-tolerant or inactive phases, requiring interferon treatment in rare cases.
Area of Science:
- Hepatology
- Immunology
- Pediatrics
Background:
- Hepatitis B virus (HBV) infection in mothers poses a risk to neonates.
- Neonatal serovaccination is standard but not fully protective against HBV transmission.
- Chronic hepatitis B is a common outcome in infected children.
Purpose of the Study:
- To summarize the outcomes of neonatal Hepatitis B infection.
- To describe the phases of chronic Hepatitis B in children.
- To outline treatment strategies for pediatric Hepatitis B.
Main Methods:
- Review of existing literature on neonatal Hepatitis B transmission and outcomes.
- Analysis of disease progression in pediatric HBV cases.
- Evaluation of treatment efficacy for chronic Hepatitis B in children.
Main Results:
- Hepatitis B develops in less than 5% of neonates from infected mothers, despite vaccination.
- The majority of infected children progress to chronic hepatitis.
- Most pediatric cases are characterized by an immune-tolerant or inactive phase.
Conclusions:
- Neonatal Hepatitis B infection, though reduced by vaccination, can lead to chronic disease.
- Understanding the immune phases is crucial for managing pediatric Hepatitis B.
- Interferon is the primary treatment for chronic Hepatitis B when intervention is necessary.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...